thomasbourgeron.bsky.social
@thomasbourgeron.bsky.social
Thank you Kevin !
December 5, 2025 at 5:01 PM
Merci Marija !!! This is highly appreciated!
December 4, 2025 at 9:48 AM
The paper is here :

www.medrxiv.org/content/10.1...
www.medrxiv.org
December 3, 2025 at 6:45 PM
#4/5 This work has been made possible thanks to the participants and to the help of the Autism Representative (A Reps) from @AIMS 2 Trials 🙏. A FAQ 📋 has been added to explain the main results of the paper.
Follow us on @aims2trials.bsky.social and @r2d2mh.bsky.social MH for more information 🗣️!
December 3, 2025 at 6:30 PM
#3/5 By bridging molecular and neural phenotypes with cognitive and behavioral outcomes, this work helps to decipher the heterogeneity of autism and may in future inform the personalized support that each autistic person and their family wants and needs 💙.
December 3, 2025 at 6:30 PM
#2/5 The LEAP InovAND cohort brings together 5,549 individuals: 2,061 with autism, 62 with intellectual deficiency, 2,551 relatives, and 875 non autistic people. For 2,531 participants, including 800 autistic people, we have genetics 🧬, and for 875 participants we have 🧬 and brain imaging 🧠 data.
December 3, 2025 at 6:30 PM